Cargando…
Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239007/ https://www.ncbi.nlm.nih.gov/pubmed/32445955 http://dx.doi.org/10.1016/j.phrs.2020.104933 |
| _version_ | 1783536631481892864 |
|---|---|
| author | Ceccarelli, Gabriele Nardi, Katiuscia Marchesani, Francesca |
| author_facet | Ceccarelli, Gabriele Nardi, Katiuscia Marchesani, Francesca |
| author_sort | Ceccarelli, Gabriele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7239007 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72390072020-05-20 Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” Ceccarelli, Gabriele Nardi, Katiuscia Marchesani, Francesca Pharmacol Res Article Elsevier Ltd. 2020-08 2020-05-20 /pmc/articles/PMC7239007/ /pubmed/32445955 http://dx.doi.org/10.1016/j.phrs.2020.104933 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ceccarelli, Gabriele Nardi, Katiuscia Marchesani, Francesca Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title | Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title_full | Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title_fullStr | Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title_full_unstemmed | Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title_short | Letter to the Editor in response to the article “Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?” |
| title_sort | letter to the editor in response to the article “could il-17 represent a new therapeutic target for the treatment and/or management of covid-19-related respiratory syndrome?” |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239007/ https://www.ncbi.nlm.nih.gov/pubmed/32445955 http://dx.doi.org/10.1016/j.phrs.2020.104933 |
| work_keys_str_mv | AT ceccarelligabriele lettertotheeditorinresponsetothearticlecouldil17representanewtherapeutictargetforthetreatmentandormanagementofcovid19relatedrespiratorysyndrome AT nardikatiuscia lettertotheeditorinresponsetothearticlecouldil17representanewtherapeutictargetforthetreatmentandormanagementofcovid19relatedrespiratorysyndrome AT marchesanifrancesca lettertotheeditorinresponsetothearticlecouldil17representanewtherapeutictargetforthetreatmentandormanagementofcovid19relatedrespiratorysyndrome |